A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ABS / Ankaferd Blood Stopper

[Related PubMed/MEDLINE]
Total Number of Papers: 136
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ABS  (>> Co-occurring Abbreviation)
Long Form:   Ankaferd Blood Stopper
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Ankaferd blood stopper as a new strategy to avoid early complications after transradial procedures: A randomized clinical trial. CSG, TRA
2018 Ankaferd Blood Stopper with antibiofilm potential successfully inhibits the extracellular matrix degradation enzymes and promotes wound healing of 3T3 fibroblasts in vitro ---
2018 Ankaferd Influences mRNA Expression of Iron-Regulated Genes During Iron-Deficiency Anemia. Ankrd37, FAC, IDA, TfR
2018 Comparison of the mechanical properties of platelet-rich fibrin and ankaferd blood stopper-loaded platelet-rich fibrin. fMax, PRF
2018 Degenerative effect of Ankaferd Blood Stopper on mice peripheral sensory neurons in vitro. DRG
2018 Evaluation of the chemopreventive effects of Ankaferd Bloodstopper in 7,12-dimethylbenz[a]anthracene-induced oral epithelial dysplasia. DMBA
2018 Hemostatic effects of adrenaline and Ankaferd (blood stopper) during orthodontic attachment bonding ---
2018 Investigation of the effect of combined use of alloplastic-based tricalcium phosphate bone graft and antihemorrhagic plant extract (ABS) on bone regeneration in surgically induced bone defects in nondiabetic rats: an experimental animal study TCP
2018 Therapeutic and preventative effects of ankaferd blood stopper in an experimental necrotizing enterocolitis model. NEC
10  2018 Topical blood stopper agents during adenoid surgery in young children; a prospective randomized controlled trial. ---
11  2017 Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. FC, FS
12  2017 Does the application of Ankaferd Blood Stopper rectally have positive effects on the healing of colorectal anastomosis and prevention of anastomotic leakage? An experimental study. ---
13  2017 Effect of Ankaferd Blood Stopper on Skin Superoxide Dismutase and Catalase Activities in Warfarin-Treated Rats. CAT, PT, SOD
14  2017 Effects of Ankaferd BloodStopper on bone healing in an ovariectomized osteoporotic rat model. ---
15  2017 Effects of Ankaferd BloodStopper on dermal healing in diabetic rats. STZ
16  2017 Neuromuscular degenerative effects of Ankaferd Blood Stopper in mouse sciatic nerve model. CMAP, MNCV
17  2017 Postlaminectomy Bone and Scar Formations in Presence of Ankaferd Blood Stopper and Bitter Melon (Momordica Charantia): An Experimental Study. MC, PF
18  2016 Ankaferd blood stopper enhances healing after osseous grafting in patients with intrabony periodontal defects. ACB, GR, PPD
19  2016 Comparison of microporous polysaccharide hemospheres and Ankaferd Blood Stopper in a rabbit epistaxis model. MPH
20  2016 Comparison of the hemostatic effects of oxidized cellulose and calcium alginate in an experimental animal model of hepatic parenchymal bleeding. CA, OC
21  2016 Effect of ankaferd blood stopper in experimental peritoneal adhesion model. ---
22  2016 Effect of Ankaferd Blood Stopper on muscle healing. ---
23  2016 Effect of bleeding on nerve regeneration and epineural scar formation in rat sciatic nerves: an experimental study. EMG
24  2016 Effect of the plant-based hemostatic agent Ankaferd Blood Stopper on the biocompatibility of mineral trioxide aggregate. FBR, MTA, NBF
25  2016 Hemostasis vs. epidural fibrosis?: A comparative study on an experimental rat model of laminectomy. MPH
26  2016 Hemostatic Efficacy and Histopathological Effects of Ankaferd Blood Stopper in an Experimental Rat Model of Cyclophosphamide-induced Hemorrhagic Cystitis. CON, CYP, HC, i.p
27  2016 In Vitro Efficacy of the Ankaferd Galenic Hemostatic Extract as a Germicidal Agent. ---
28  2016 Intraarticular Ankaferd blood stopper application increases cartilagedegeneration: an experimental study. ---
29  2016 Splenic artery embolization with Ankaferd blood stopper in a sheep model. ---
30  2016 The antioxidant and antimutagenic activities of Ankaferd blood stopper,a natural hemostatic agent used in dentistry. ---
31  2016 Treatment of hemorrhagic gastritis by Ankaferd blood stopper versus Omeprazole: experimental randomized rat models. ---
32  2016 Ultrastructural analyses of the novel chimeric hemostatic agent generated via nanotechnology, ABS nanohemostat, at the renal tissue level. SEM
33  2015 Ankaferd blood stopper decreases postoperative bleeding and number of transfusions in patients treated with clopidogrel: a double-blind, placebo-controlled, randomized clinical trial. ASA, CABG
34  2015 Bond strengths of a self-etching adhesive to dentin surfaces treated with saliva, blood, and different hemostatic agents. CSE
35  2015 Effect of Ankaferd blood stopper on tendon healing: an experimental study in a rat model of Achilles tendon injury. ---
36  2015 Effects of hemostatic agents on shear bond strength of orthodontic brackets. SBS
37  2015 Experimental evaluation of the effects of Ankaferd Blood Stopper and collagenated heterologous bone graft on bone healing in sinus floor augmentation. CHBG
38  2015 Hemostatic efficacy of a traditional medicinal plant extract (Ankaferd Blood Stopper) in bleeding control. ---
39  2015 Histopathological evaluation of Ankaferd blood stopper use in the rabbit septoplasty model. ---
40  2015 In Vivo Healing Effects of Ankaferd Blood Stopper on the Residual Pancreatic Tissue in a Swine Model of Distal Pancreatectomy. ---
41  2015 Successful Treatment of Refractory Gastrointestinal Bleeding by Systemic (Oral) Ankaferd Blood Stopper in a Patient with Glanzmann Thrombasthenia. GT
42  2015 The effect of hemostatic agents and tissue adhesive on injured peripheral nerve healing in rats - Part I. Electrophysiological study. BC, CAP, GS, NCV, ORC
43  2015 The effects of ankaferd blood stopper on the recovery process in an experimental oesophageal perforation model. ---
44  2015 Unpredicted effects of Ankaferd on cartilage tissue. ---
45  2014 Beneficial effects of Ankaferd Blood Stopper on dermal wound healing: an experimental study. ---
46  2014 Correlation between International Normalized Ratio values and sufficiency of two different local hemostatic measures in anticoagulated patients. INR, OAT
47  2014 Effective management of hemoptysis via endobronchial application of Ankaferd hemostat. ---
48  2014 Effects of Ankaferd Blood Stopper and Celox on the tissue factor activities of warfarin-treated rats. PT, TF
49  2014 Effects of the topical hemostatic agent Ankaferd Blood Stopper on the incidence of alveolar osteitis after surgical removal of an impacted mandibular third molar. AO
50  2014 Efficacy of Ankaferd Blood Stopper on bone healing in diabetic rats: a stereological and histopathological study. AP
51  2014 Efficiency of Ankaferd Blood Stopper used in bleeding control on intraabdominal adhesions formed postoperatively. ---
52  2014 Evaluation of intraabdominal adhesion generating potentials of ankaferd and calcium alginate used as hemostatic agents. ---
53  2014 Microvascular anastomosis using Ankaferd blood stopper: demonstration of long-term histopathologic effects on vascular tissue. ---
54  2014 New hemostatic agent: the effect of Ankaferd Blood Stopper on healing wounds in experimental skin incision model. ---
55  2014 Protective effects of Ankaferd blood stopper on aspirin-induced oxidative mucosal damage in a rat model of gastric injury. ASA, MDA, MPO, NO, SOD, TNF-alpha
56  2014 Serum M30 and M65 levels and effects of Ankaferd blood stopper in cerulein induced experimental acute pancreatitis model in rats. ---
57  2014 Success Rates of Ankaferd Blood Stopper and Ferric Sulfate as Pulpotomy Agents in Primary Molars. FS
58  2014 The efficacy of the hemostatic agent Ankaferd blood stopper on end-to-end unilateral sleeve fish-mouth anastomosis. ---
59  2013 Ankaferd blood stopper in episiotomy repair. ---
60  2013 Anti-inflammatory efficiency of Ankaferd blood stopper in experimental distal colitis model. MDA, NO, SOD
61  2013 Comparison of the effects of new folkloric hemostatic agent on peripheral nerve function: an electrophysiologic study in rats. BC, NCV, OC
62  2013 Do blood contamination and haemostatic agents affect microtensile bond strength of dual cured resin cement to dentin? ---
63  2013 Effect of a plant-based hemostatic agent on microleakage of self-etching adhesives. ---
64  2013 Evaluation of the hemostatic and histopathological effects of Ankaferd Blood Stopper in experimental liver injury in rats. Hct
65  2013 Evaluation of the hemostatic effects of Ankaferd blood stopper during dental extractions in patients on antithrombotic therapy. ---
66  2013 Experimental investigation of the effects of a blood stopper agent (ankaferd blood stopper) on bone surfaces. Md.Ar, Me.Dm, O.Ar, Ob.Ar, Tb.Ar
67  2013 Generation of Chimeric "ABS Nanohemostat" Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model. PA, PN, WITs
68  2013 Medicinal plant extract (Ankaferd Blood Stopper) application in deep tissue injuries in rats: histopathological investigation of the effect on regional and systemic tissues. ---
69  2013 Oral high-dose ankaferd administration effects on gastrointestinal system. ---
70  2013 The Effectiveness of a New Hemostatic Agent (Ankaferd Blood Stopper) for the Control of Bleeding following Tooth Extraction in Hemophilia: A Controlled Clinical Trial. ---
71  2013 TNF-alpha, IL-1beta, and oxidative stress during fracture healing with or without ankaferd. IL-10, IL-1beta, TNF-alpha
72  2013 Topical application of ankaferd hemostat in a patient with gastroduodenal amyloidosis complicated with gastrointestinal bleeding. ---
73  2013 [In Vitro Effect of Ankaferd Blood Stopper, a Plant Extract Against Mycobacterium tuberculosis Isolates]. MDR, STR
74  2012 Antibacterial effect of a new haemostatic agent on oral microorganisms. CHX, FS
75  2012 Beneficial effects of Ankaferd Blood Stopper on caustic esophageal injuries: an experimental model. SI
76  2012 Effects of a new hemostatic agent Ankaferd Blood Stopper()on the intraocular tissues in rat model. BSS
77  2012 Effects of folk medicinal plant extract Ankaferd Blood Stopper() in vital primary molar pulpotomy. FC
78  2012 Efficacy of ankaferd blood stopper application on non-variceal upper gastrointestinal bleeding. GIS, NVUGIB
79  2012 Endoscopic topical application of Ankaferd Blood Stopper in gastrointestinal bleeding. UGI
80  2012 Evaluation of cytotoxicity of a new hemostatic agent Ankaferd Blood Stopper using different assays. LDH
81  2012 Influence of Ankaferd Blood Stopper on shear bond strength of bonding systems. ---
82  2012 Massive haematuria successfully managed by intravesical Ankaferd in a haemodialysis patient complicated with disseminated intravascular coagulation. DIC
83  2012 Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat. ---
84  2012 Prohemostatic and antithrombin activities of Ankaferd hemostat are linked to fibrinogen gamma chain and prothrombin by functional proteomic analyses. ---
85  2012 Successful topical application of Ankaferd blood stopper in a patient with life-threatening fundal variceal bleeding despite cyanoacrilate injection. ---
86  2012 The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge. EPCR, HUVECs, LPSs, PAI-1
87  2012 Topical Ankaferd hemostat application for the management of oral cavity bleedings in children with hemorrhagic diathesis. ---
88  2011 A new candidate as a hemostatic agent for difficult situations during variceal bleeding: Ankaferd blood stopper. ---
89  2011 A new haemostatic agent's effect on the success of calcium hydroxide pulpotomy in primary molars. CH
90  2011 Ankaferd blood stopper is more effective than adrenaline plus lidocaine and gelatin foam in the treatment of epistaxis in rabbits. AL, GF, HE, PTAH
91  2011 Ankaferd hemostat in the management of gastrointestinal hemorrhages. GI
92  2011 Cytotoxicity of a new hemostatic agent on human pulp fibroblasts in vitro. DMEM, MTT
93  2011 Effects of the folk medicinal plant extract Ankaferd Blood Stopper on the ocular surface. BSS
94  2011 Evaluation of a haemostatic agent in rabbits. ---
95  2011 Haemostatic effect of Ankaferd Blood Stopper() seen during adenoidectomy. SS
96  2011 In Vitro Antifungal Activity of Ankaferd Blood Stopper Against Candida albicans. MIC
97  2011 Percutaneous ankaferd injection to in vivo liver tissue in comparison to ethanol in an experimental rat model. HCC
98  2011 Reversible protease-activated receptor 1 downregulation mediated by Ankaferd blood stopper inducible with lipopolysaccharides inside the human umbilical vein endothelial cells. HUVEC, min, PAR-1
99  2011 Successful management of bleeding after dental procedures with application of blood stopper: a single center prospective trial. ---
100  2011 Surgical and histopathological effects of topical Ankaferd hemostat on major arterial vessel injury related to elevated intra-arterial blood pressure. ---